About Professor Michael Solomon

Professor Solomon’s research interests lie in developing maximally invasive techniques for advanced pelvic malignancy, clinical trials of minimally invasive colorectal surgery, assessment and performance of randomized and alternative clinical trial designs for surgical operations and treatment decision making in advanced and recurrent rectal cancer.

Professor Solomon’s surgical expertise is in minimally and maximally invasive colorectal surgery with the foundation of a multi-disciplined complex pelvic surgery for advanced and recurrent malignancy unit, expertise in inflammatory bowel disease and pelvic floor disorders as well as laparoscopic colorectal surgery.

Professor Michael Solomon is a Consultant Surgeon and Academic Head of the Department of Colorectal Surgery at the Royal Prince Alfred Hospital in Sydney. He is Professor of Surgical Research at the University of Sydney, is a past President of the Colorectal Surgical Society of Australia & New Zealand (CSSANZ) and is currently a Board Member of the NSW State Cancer Institute. He was awarded the prestigious RPA Foundation Research Medal in 2014 being the first surgeon to be given this honour. He was awarded an Honorary Fellowship of the Royal College of Surgeons of Ireland in 2014; appointed Honorary Visiting Professorship with the Memorial Sloan Kettering Cancer Centre in New York in 2015; awarded for Outstanding Service to the Community by RACS in 2016. More recently he was awarded the Sir Peter Freyer Memorial Medal by the National University of Ireland; and Travelling Fellowship & Oration by the St Mark's Hospital, UK.He recently was awarded a Doctorate of Medicine from the National University of Ireland for his work in surgical health outcomes, patient choice and clinical trials of minimally invasive colorectal surgery. He previously was awarded the Doctorate of Medical Science (DMedSc) the highest degree awarded by the Sydney Medical School of the University of Sydney for his work contributing to the evolution of pelvic exenteration for advanced and recurrent malignancy.

Professor Solomon has extensive experience in clinical surgical research, has published 296 papers, presented 14 international named lectures and obtained over 15 million dollars in peer-reviewed research grants. Also Founding Director/Head of SOuRCe, Surgical Outcomes Research Centre, established 2004, a multidisciplinary, academic research unit dedicated to advancement of evidence-based surgical practice through outcomes-orientated surgical research. He was appointed inaugural Chairman of the RPA Institute of Academic Surgery 2014. This novel Institute focuses on enhancing academic surgery by fostering and mentoring academic careers, surgical education, social media, global health, current surgical research and most critically the future of surgery and has led to 13 academic appointments at the University of Sydney as part of the Institute.

Selected publications

1. O'Shannassy SJ, Brown KGM, Steffens, Solomon MJ. Referral patterns and outcomes of a highly specialised pelvic exenteration multidisciplinary team meeting: A retrospective cohort study. European Journal of Surgical Oncology 2020; 46(6):1138-1143


2. Koh CE, Brown KGM, Steffens D, Young J, Salkeld G, Solomon MJ. What constitutes a clear margin in patients with locally recurrent rectal cancer undergoing pelvic exenteration? Annals of Surgery 2020; DOI: 10.1097/SLA.0000000000003834


3. Denost Q, Solomon MS, Tuech JJT, Faucheron JLF, Mehrdad JM, Lefevre JL, Rullier ER, Heriot AH, Austin KA, Lee PL, Brown WB, Maillou-Martinaud HMM, Savel HS, Quintard BQ, Broc GB, Saillour-Glénisson FSG. International prospective benchmark pilot study in primary T4 and locally recurrent rectal cancer. British Journal of Surgery 2020; DOI:10.1002/bjs.11854


4. The PelvEx Collaborative. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer. Results from an International Collaboration. Annals of Surgery 2019:269:315-321.


5. Stevenson ARL, Solomon MJ, Brown SSB, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Wilson K, Hague W, Simes J, on behalf of the Australasian Gasro-Intestinal Trails Group (AGITG) ALaCaRT investigators. Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial. Annals of Surgery 2019; 269:596-602


6. Brown KGM, Solomon MJ, Mahon K, O'Shannassy S. Management of colorectal cancer. BMJ 2019; 366:I4561: doi.org/10.1136/bmj.l4561


7. Brown KGM, Solomon MJ, Lau YC, Steffens D, Austin KKS, Lee PJ. Sciatic and femoral nerve resection during extended radical surgery for advanced pelvic tumours: long-term survival, functional and quality of life outcomes. Annals of Surgery 2019; [DOI: 10.1097/SLA.0000000000003390


8. Brown KGM, Solomon MJ, Latif ER, Koh CE, Vasilaras A, Eisinger D, Sved P. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy. Journal of Surgical Oncology 2017; 115(3); 307-311


9. Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J. Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer The ALaCaRT Randomized Clinical Trial. JAMA 2015; 314:1356 -1363


10. Brown KGM, Koh CE, Vasilaras A, Eisinger D, Solomon MJ. Clinical algorithms for the diagnosis and management of urological leaks following pelvic exenteration. European Journal of Surgical Oncology 2014; 40:775-781